Rheumatoid Arthritis Drug Linked to Fewer Deaths in COVID Patients

Two new studies have revealed that rheumatoid arthritis medication tocilizumab is associated with lower death rates in COVID-19 patients receiving mechanical ventilation. Tocilizumab blocks interleukin-6 (IL-6), an inflammatory protein involved in a potential “cytokine storm” that can lead to respiratory failure in patients with coronavirus. In the first single-center observational …

Read More »